Ros Matthew E
- SEC CIK
- 0001461613
No open-market purchases or sales filed in the past year.
Current role at each company
- JSPR Jasper Therapeutics, Inc.Chief Operating Officeras of Jul 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ros Matthew E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 (view filing)7:10 PM ET | Jul 20 | 2 days | Ros Matthew EChief Operating Officer | PPurchaseVoting Common Stock | +53.7K | – | – | –881 after | Derivative |